antirheumatic


Also found in: Medical.

antirheumatic

(ˌæntɪruːˈmætɪk)
adj
acting against rheumatism
n
a drug or treatment that acts against rheumatism
Translations
References in periodicals archive ?
Taltz may be administered alone or in combination with a conventional disease-modifying antirheumatic drug (e.g.
Taltz may be administered alone or in combination with a conventional disease-modifying antirheumatic drug, corticosteroids, non-steroidal anti-inflammatory drugs and/or analgesics.
Male sex, having early RA, being disease-modifying antirheumatic drug-naive, and having lower disease activity scores in remission were positively associated with SR.
Currently, disease-modifying antirheumatic drugs (DMARDs)*2 including Methotrexate (MTX) and biologies, are used to treat rheumatoid arthritis.
Speaking at a press conference of the Cyprus Antirheumatic Association (CAA), Ioannou noted that "in Europe, rheumatic diseases constitute the most common cause of absence from work, and account for 50 per cent of long-term functional inabilities."
The researchers matched 59,627 patients who received the herpes zoster vaccine with 119,254 unvaccinated patients, based on age, sex, race, calendar year, autoimmune disease type, and use of autoimmune drugs (biologics, disease-modifying antirheumatic drugs, and glucocorticoids).
Patients with severe scleroderma with significant internal organ damage who "are improved and off of disease-modifying antirheumatic drugs after 10 or more years from treatment is something new in autoimmune disease," said Dr.
While there is no cure for RA--an autoimmune disease that affects more than 1.3 million Americans--treatment with powerful therapies such as biologic or disease-modifying antirheumatic drugs can lead to remission of symptoms.
Doctors may prescribe anti-inflammatory drugs, antirheumatic drugs, exercise, and complementary therapies.
(NYSE: PFE) has received European Commission (EC) approval of Xeljanz (tofacitinib citrate) 5 mg twice daily in combination with methotrexate for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug therapy, the company said.
Scientists analysed the records of patients taking disease-modifying antirheumatic drugs (DMARDs) and those who were not.